Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does OXALIPLATIN Cause Contraindicated product administered? 10 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 10 reports of Contraindicated product administered have been filed in association with OXALIPLATIN (Oxaliplatin). This represents 0.0% of all adverse event reports for OXALIPLATIN.

10
Reports of Contraindicated product administered with OXALIPLATIN
0.0%
of all OXALIPLATIN reports
3
Deaths
6
Hospitalizations

How Dangerous Is Contraindicated product administered From OXALIPLATIN?

Of the 10 reports, 3 (30.0%) resulted in death, 6 (60.0%) required hospitalization.

Is Contraindicated product administered Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for OXALIPLATIN. However, 10 reports have been filed with the FAERS database.

What Other Side Effects Does OXALIPLATIN Cause?

Diarrhoea (4,963) Nausea (4,250) Neuropathy peripheral (3,662) Off label use (3,603) Neutropenia (3,391) Vomiting (3,383) Disease progression (3,370) Thrombocytopenia (2,886) Dyspnoea (2,779) Pyrexia (2,269)

What Other Drugs Cause Contraindicated product administered?

ABATACEPT (13,559) METHOTREXATE (13,121) ETANERCEPT (12,062) TOCILIZUMAB (11,547) ADALIMUMAB (11,270) LEFLUNOMIDE (11,206) HYDROXYCHLOROQUINE (10,557) RITUXIMAB (10,479) INFLIXIMAB (9,618) SULFASALAZINE (8,698)

Which OXALIPLATIN Alternatives Have Lower Contraindicated product administered Risk?

OXALIPLATIN vs OXAPROZIN OXALIPLATIN vs OXAZEPAM OXALIPLATIN vs OXCARBAZEPINE OXALIPLATIN vs OXITRIPTAN OXALIPLATIN vs OXOMEMAZINE

Related Pages

OXALIPLATIN Full Profile All Contraindicated product administered Reports All Drugs Causing Contraindicated product administered OXALIPLATIN Demographics